학술논문
Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial)
Document Type
Article
Author
Ruddy, K.J.; Liu, M.C.; Zheng, Y.; Tayob, N.; Hu, J.; Faggen, M.G.; Sella, T.; Constantine, M.; Briccetti, F.M.; Rosenberg, S.; DeMeo, M.K.; Burstein, H.J.; Winer, E.P.; Krop, I.E.; Partridge, A.H.; Tolaney, S.M.; Dang, C.T.; Yardley, D.A.; Isakoff, S.J.; Mulvey, T.M.; Valero, V.V.; Bose, R.; Weckstein, D.J.; Wolff, A.C.; Reeder-Hayes, K.E.; Rugo, H.S.; Ramaswamy, B.; Zuckerman, D.S.; Hart, L.L.; Gadi, V.K.; Cheng, K.L.; Schneider, B.P.; Merrill Garrett, A.; Kelly Marcom, P.; Albain, K.S.; DeFusco, P.A.; Tung, N.M.; Ardman, B.M.; Nanda, R.; Jankowitz, R.C.; Rimawi, M.; Abramson, V.; Pohlmann, P.R.; Van Poznak, C.; Forero-Torres, A.
Source
In: Breast Cancer Research and Treatment . (Breast Cancer Research and Treatment, August 2021, 189(1):103-110)
Subject
Language
English
ISSN
15737217
01676806
01676806